Log In
Print this Print this

BAY41-6551, NKTR-061, Amikacin Inhale

  Manage Alerts
Collapse Summary General Information
Company Nektar Therapeutics
DescriptionSecond-generation nebulizer delivery of amikacin
Molecular Target Ribosomal 30S subunit
Mechanism of ActionRibosomal 30S subunit inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPneumonia
Indication DetailsTreat Gram-negative pneumonia in intubated and mechanically-ventilated patients; Treat Gram-negative pneumonia in mechanically-ventilated patients; Treat hospital-acquired pneumonia (HAP); Treat ventilator-associated pneumonia (VAP)
Regulatory Designation


Bayer AG

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today